251 results
Expansion of IBD Qorus Initiative
IBD Qorus is the Crohn’s & Colitis Foundation’s quality improvement initiative designed to drive improved care and health outcomes for adult patients with IBD. Healthcare teams from centers across the United States come together to learn and share best practices for improved health care delivery...
Read more... Sit Down with DINE-CD Study Lead Investigator Dr. Jim Lewis (vlog)
We know a topic of major interest within IBD community is the role that diet plays in the management of Crohn’s disease and ulcerative colitis. Unfortunately, there has been little scientific research into how diet may impact IBD but the good news is we are working to change that.
In 2016, the Cr...
Read more... Q&A with Dr. Randy Longman, IBD Researcher
Please briefly describe your research interests in the relationship between joint inflammation and gut inflammation.
Randy: Many IBD patients – up to one third - experience significant extra-intestinal manifestations of the disease. The most common is joint inflammation. There ar...
Read more... Dr. Neil Nandi Provides Update on Fecal Microbiota Transplantation (vlog)
Ever wonder what fecal microbiota transplantation is? Check out our latest vlog featuring Dr. Neil Nandi, Director of the Inflammatory Bowel Disease Center at Drexel University, College of Medicine.
Back to Clinical Trials Community >
Read more... FDA Approves New Ulcerative Colitis Treatment (tofacitinib)
On May 30th of this year, the Food and Drug Administration (FDA) approved a new treatment for moderately to severely active ulcerative colitis. Tofacitinib, which is made by Pfizer Labs, was previously approved in 2012 for rheumatoid arthritis and in 2017 for psoriatic arthritis.
The F...
Read more... Clinical Trials Day
Each May, Clinical Trials Day is observed to raise awareness of clinical trials and honor research professionals for their commitment and contributions to public health and medical progress. Without clinical trials, we wouldn't have medications available to treat IBD. That's why patient enrollment i...
Read more... Crohn’s Disease and Ulcerative Colitis Patient Perspectives on Clinical Trials and Participation
Clinical trials play a key role in the development and approval of new treatment options for IBD patients. In order to understand patient perceptions and improve recruitment, the Crohn's & Colitis Foundation conducted in-person focus groups over a four-month period in 2016, the results of which ...
Read more... Specific type of gut bacteria can enable development and dissemination of colorectal cancer
Scientists from Dana-Farber Cancer Institute at Harvard Medical School recently reported that a specific type of bacteria that reside in the gut can enable development and dissemination of colorectal cancer.
This type of bacteria, Fusobacterium, was previously shown to be associated with IB...
Read more... Guest Author Lilly Stairs: IBD Patient and Patient Advocate Dedicated to Advancing Research
Each of us encounters defining moments in our lives. Moments that fundamentally shape who we are, moments that reveal our true selves. I’m convinced that our deepest selves are never fully unmasked until we are faced with moments that rattle us to our core. Moments that challenge us to make a life-a...
Read more... Q&A with Dr. Meena Bewtra, IBD Patient and Researcher
March is Women’s History Month. The Crohn’s & Colitis Foundation would like to take this opportunity to put the spotlight on some of the fearless women leaders committed to making a difference for IBD patients. For this edition, Cecile Norris, Senior Research Manager at the Foundation, interview...
Read more...